Ambuja Cements Limited (AMBUJACEM) — Announcement | 15 September 2025(3 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement 🔴 High Importance Neutral 📄 PDF

Ambuja Cements Limited announced the cessation of Mr. M R Kumar as Nominee Director of Life Insurance Corporation of India (LIC) effective September 15, 2025, following completion of his tenure. The LIC Letter dated August 21, 2025 notified the company of this change. This is a routine board-level transition with no operational or financial implications disclosed.

2 Announcement Neutral 📄 PDF

Ambuja Cements Limited published a shareholder notice announcing the IEPFA's 100-day 'Saksham Niveshak' campaign running July 28 to November 6, 2025. The initiative urges shareholders to update KYC details, claim unpaid/unclaimed dividends, and register nominations through designated RTA channels to prevent automatic transfer of funds to the Investor Education and Protection Fund. Shareholders can contact MUFG Intime India Private Limited or use the SWAYAM portal for assistance.

3 Announcement Neutral 📄 PDF

Ambuja Cements Limited announced participation in the JP Morgan 10th Annual India Conference on September 22, 2025, in Mumbai. Management will engage with investors and analysts through 1x1 and group meetings from 9:00 AM to 6:00 PM IST. The company confirmed discussions will be limited to publicly available information with no unpublished price-sensitive disclosures, as mandated by SEBI regulations.

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMBUJACEM — Free

Free account · 2 AI queries/day